Results 71 to 80 of about 7,086 (183)
ABSTRACT Gallbladder carcinoma is an aggressive malignancy often diagnosed at an advanced stage. Skeletal metastasis, especially mixed lytic‐sclerotic lesions, is rare and typically occurs late. This report highlights an unusual presentation where widespread bony metastases were the initial manifestation, leading to the diagnosis of gallbladder ...
Shivali Rao +2 more
wiley +1 more source
Xanthoma Disseminatum with Tumor-Like Lesion on Face
Xanthoma disseminatum (XD) is a rare benign mucocutaneous xanthomatosis that is classified as a benign non-Langerhans cell histiocytosis. We report a 62-year-old man who presented with widespread yellow-brown papulonodular and tumoral lesions on face ...
Habib Ansarin +3 more
doaj +1 more source
Baby with neonatal systemic juvenile xanthogranuloma born within a cross-cousin marriage
Juvenile xanthogranuloma is a non-Langerhans cell histiocytosis seen most commonly in childhood and adolescence. Extracutaneous involvement is rare. We report an interesting and extremely rare case of systemic (skin, lung, spleen, and colon) “juvenile ...
Hikmet Tekin Nacaroglu +6 more
doaj +1 more source
A large multilobulated cutaneous nodule in infancy
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Hannah Wahida +2 more
wiley +1 more source
ABSTRACT Background Adolescent and young adult childhood cancer survivors (AYA‐CCS) face elevated risks of chronic health conditions and premature mortality further exacerbated by poor lifestyle behaviors including physical inactivity, poor nutrition, and substance use.
C. Gélinas‐Gagné +11 more
wiley +1 more source
Multiple cutaneous reticulohistiocytoma
Multicentric reticulohistiocytosis is a rare non-Langerhans cell histiocytosis characterized in its full form by severe destructive arthritis, cutaneous nodules, and systemic manifestations.
Karishma D Hemmady +2 more
doaj +1 more source
Successful treatment of non-Langerhans cell histiocytosis with the MEK inhibitor trametinib: a multicenter analysis. [PDF]
Aaroe A +12 more
europepmc +1 more source
MEK inhibition achieves robust and durable responses in Erdheim–Chester disease
Abstract Erdheim–Chester disease (ECD) is a rare histiocytic neoplasm characterized by heterogeneous clinical manifestations and limited evidence to guide targeted therapy. While MEK inhibitors (MEKi) are increasingly used, data on their real‐world efficacy, durability, and safety remain incomplete.
Francesco Pegoraro +34 more
wiley +1 more source
Juvenile Xanthogranuloma: Case Report and Literature Review
Sadegh Vahabi-Amlashi, Masoumeh Hoseininezhad, Zahra Tafazzoli Cutaneous Leishmaniasis Research Center, Mashhad University of Medical Sciences, Mashhad, IranCorrespondence: Zahra TafazzoliDepartment of Dermatology, Imam Reza Hospital, Ibn e Sina Street ...
Vahabi-Amlashi S +2 more
doaj
ABSTRACT Erdheim–Chester disease (ECD) is a rare histiocytic disorder with heterogeneous clinical manifestations. Central nervous system (CNS) involvement is associated with poor prognosis. Although targeted therapies have improved outcomes in patients with mitogen‐activated protein kinase (MAPK) pathway alterations, optimal treatment strategies for ...
Naoki Watanabe +8 more
wiley +1 more source

